Why the study?
Does immunoadsorption improve hemodynamic parameters in patients with severe dilated cardiomyopathy?
Population
9 patients with severe dilated cardiomyopathy, mean age 43.5 years, on stable drug therapy including ACE…
Design
Case_series
Follow-up
5 days
Authors
Loading...
May improve acute hemodynamics in severe dilated cardiomyopathy; leaves open need for randomized outcome trials.
Does immunoadsorption improve hemodynamic parameters in patients with severe dilated cardiomyopathy?
Immunoadsorption over 5 days significantly improved cardiac output and reduced systemic vascular resistance in patients with severe dilated cardiomyopathy.
Dörffel et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: